“☂NO.1작대% 텔레@HI7856 작업대출성공 작대성공 작대후기❤️☂”的搜索结果，显示 61-70 项，共有 10789 项

1. 乳腺专科门诊 - 临床试验 - 妙佑医疗国际

   Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...

2. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

3. 乳腺癌- 医生与科室- 妙佑医疗国际

   研究领域包括：. 开创性乳房成像技术，例如动态对比增强型MRI、对比增强型数字化乳房成像术和分子乳腺成像术; 控制病毒的毒力来治疗非 ...

4. 血液科- 临床试验- 妙佑医疗国际

   ... (1) Cohort 1 focuses on cancers displaying a high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

7. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

8. 乳腺癌- 医生与科室- 妙佑医疗国际

   研究领域包括：. 开创性乳房成像技术，例如动态对比增强型MRI、对比增强型数字化乳房成像术和分子乳腺成像术; 控制病毒的毒力来治疗非 ...

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...